Establishment and Characterization of Amitrole-Induced Mouse Thyroid Adenomatous Nodule-Derived Cell Lines
- 24 January 2024
- journal article
- research article
- Published by SAGE Publications in Thyroid®
- Vol. 34 (4) , 496-509
Abstract
Background Thyroid cancer cell lines have been of great value for the study of thyroid cancer. However, the availability of benign thyroid adenoma cell lines is limited. Methods Cell lines were established from thyroid adenomatous nodules that developed in mice treated with the goitrogen amitrole. Expression of epithelial, mesenchymal and thyroid markers of these established cell lines was determined and the effect of lentivirus-transduced overexpression of NKX2-1, a master regulator of thyroid development, on the thyroid marker expression was examined. Signal transduction and cell proliferation were evaluated after treatment with insulin-like growth factor-I (IGF-I) and the selective IGF-I receptor (IGF-IR) inhibitor NVP-ADW742. Xenograft studies were performed to examine tumorigenicity of the cells in mice. Whole genome sequencing (WGS) was used to comprehensively determine the genetic mutations in the established two cell lines. Results Five mouse thyroid adenomatous nodules-derived cell lines named CAT (cells from amitrole treated thyroids) were established. Among these, two cell lines, CAT458/458s (CAT458s: a sub-line of CAT458) and CAT459 were found to be positive for epithelial markers, and negative for a mesenchymal marker. NKX2-1-positive CAT459 cells showed higher mRNA expression of some thyroid differentiation markers than NKX2-1-negative CAT458s cells, and NKX2-1 overexpression increased and/or induced their expression. IGF-I signaling was transduced in thyroid stimulating hormone receptor (Tshr)-negative CAT458s and 459 cells, and NVP-ADW742 suppressed their proliferation. No tumors developed in mice after subcutaneous injection of CAT458s or 459 cells. WGS analysis revealed the presence of missense mutations in the tumor suppressor genes such as Polk (encoding DNA polymerase kappa) and Tgfb1 (encoding transforming growth factor beta 1), while no mutations were found in the prominent thyroid cancer-related genes Braf, Trp53 (encoding p53), and Tert (encoding telomerase reverse transcriptase). Conclusion Two mouse thyroid adenomatous nodule-derived cell lines with different thyroid differentiation marker expression were established. NKX2-1 induced partial differentiation of these cell lines. They lacked tumorigenicity and prominent gene mutations involved in thyroid cancer development, while missense mutations were found in some tumor suppressors as revealed by WGS. The CAT458s and 459 provide a new tool to further clarify the process of thyroid multi-step carcinogenesis and differentiation.Keywords
This publication has 68 references indexed in Scilit:
- Retinoid acid receptor expression is helpful to distinguish between adenoma and well-differentiated carcinoma in the thyroidVirchows Archiv, 2013
- Molecular pathogenesis and mechanisms of thyroid cancerNature Reviews Cancer, 2013
- Generation of functional thyroid from embryonic stem cellsNature, 2012
- Thyroid cancer cell lines: an overviewFrontiers in Endocrinology, 2012
- MULTIPRED2: A computational system for large-scale identification of peptides predicted to bind to HLA supertypes and allelesJournal of Immunological Methods, 2011
- A method and server for predicting damaging missense mutationsNature Methods, 2010
- Role of NKX2-1 in N-bis(2-hydroxypropyl)-nitrosamine-induced thyroid adenoma in miceCarcinogenesis, 2009
- Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and MisidentificationThe Journal of Clinical Endocrinology & Metabolism, 2008
- SNAP predicts effect of mutations on protein functionBioinformatics, 2008
- Thyrotropin receptor gene expression in oncogene-transfected rat thyroid cells: Correlation between transformation, loss of thyrotropin-dependent growth, and loss of thyrotropin receptor gene expressionBiochemical and Biophysical Research Communications, 1990